[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-362739-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-362739-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","an-injectable-photothermal-responsive-liposome-hydrogel-co-loaded-with-bufalin-apatinib-and-ir820-for-inhibiting-postoperative-recurrence-of-colon-cancer","An Injectable Photothermal Responsive Liposome Hydrogel Co-Loaded with Bufalin, Apatinib, and IR820 for Inhibiting Postoperative Recurrence of Colon Cancer","","A thermosensitive, injectable liposome-hydrogel system was developed to curb postoperative recurrence of colon cancer by combining bufalin, apatinib, and the near-infrared photothermal agent IR820. Thermosensitive liposomes were co-loaded with bufalin and apatinib, encapsulated within an injectable PLGA-PEG-PLGA hydrogel, and further incorporated IR820 to form a photothermally responsive composite. The hydrogel’s physicochemical and rheological properties and drug release behavior were characterized, and antitumor activity was assessed in vitro and in vivo. The formulation showed strong injectability, photothermally responsive drug release, reduced migration, invasion, and angiogenesis, prolonged local retention, and significant recurrence suppression with favorable biocompatibility.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/an-injectable-photothermal-responsive-liposome-hydrogel-co-loaded-with-bufalin-apatinib-and-ir820-for-inhibiting-postoperative-recurrence-of-colon-cancer/362739/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/an-injectable-photothermal-responsive-liposome-hydrogel-co-loaded-with-bufalin-apatinib-and-ir820-for-inhibiting-postoperative-recurrence-of-colon-cancer/362739.png","ImageObject",300,407,{"name":42,"@type":43},"Taylor Morgan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-26","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main therapeutic goal of the injectable liposome hydrogel in this study?","Question",{"text":63,"@type":64},"To inhibit postoperative recurrence of colon cancer by enabling localized, near-infrared-responsive drug release and photothermal therapy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the thermosensitive liposomes and the composite hydrogel prepared?",{"text":68,"@type":64},"Thermosensitive liposomes co-loaded with bufalin and apatinib were prepared by the thin-film hydration method, then co-encapsulated with IR820 in an injectable PLGA-PEG-PLGA hydrogel to form a photothermally responsive composite.",{"name":70,"@type":61,"acceptedAnswer":71},"What key effects were observed in vitro and in vivo?",{"text":72,"@type":64},"In vitro, the hydrogel inhibited tumor cell migration, invasion, and angiogenesis; in vivo, it prolonged local drug retention and, combined with near-infrared irradiation, significantly suppressed tumor recurrence while showing favorable biocompatibility.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},362739,1790200183,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":99,"preview_page_count":33,"preview_urls":145},1099523885336,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","International Journal of Nanomedicine  \n Open Access Full Text Article  \nORIGINAL RESEARCH  \nAn Injectable Photothermal Responsive Liposome Hydrogel Co-Loaded with Bufalin, Apatinib, and IR820 for Inhibiting Postoperative Recurrence of Colon Cancer  \nAi-Jia Wang 1 , *, Huan Tian2 , *, Zhan-Peng Wang 1,*, Jiang-Xue Cheng 1, Jing Sun 1, Feng Zhao2, Ya-Jun Shi 1, Xiao-Fei Zhang 1, Jun-Bo Zou 1, Fei Luan 1, Bing-Tao Zhai 1, Dong-Yan Guo 1  \n1State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), and Shaanxi Province Key Laboratory of New Drugs and Chinese Medicine Foundation Research, Shaanxi University of Chinese Medicine, Xi’an, 712046, People’s Republic of China; 2Department of Pharmacy, Xi’an Hospital of Traditional Chinese Medicine, Xi’an, 710021, People’s Republic of China  \n*These authors contributed equally to this work  \nCorrespondence: Bing-Tao Zhai; Dong-Yan Guo, Email [zbp@sntcm.edu.cn](zbp@sntcm.edu.cn); [2051080@sntcm.edu.cn](2051080@sntcm.edu.cn)  \n\n| Background: Colon cancer ranks as the third most common malignant tumor globally. Due to incomplete surgical resection and the multidrug resistance of tumor cells, it exhibits a high postoperative recurrence rate. Consequently, there is an urgent need to develop novel therapeutic strategies to inhibit postoperative recurrence of colon cancer.\u003Cbr>Methods: Thermosensitive liposomes (Bu&Ap-Lip) co-loaded with bufalin (Bu) and apatinib (Ap) were prepared via the thin-film hydration method, with optimization of Prescription Processes. Bu&Ap-Lip was co-encapsulated with new indocyanine green (IR820) within an injectable PLGA-PEG-PLGA hydrogel, establishing a photothermally responsive composite hydrogel (Bu&Ap-Lip@IR820 Gel) . The system characterized the physicochemical properties, rheological characteristics, and drug release behavior of the hydrogel, and further evaluated its in vitro antitumor activity and in vivo efficacy against postoperative recurrence of colon cancer.\u003Cbr>Results: Bu&Ap-Lip@IR820 Gel demonstrated excellent injectability and photothermally responsive drug-release properties. In vitro cellular experiments demonstrated that Bu&Ap-Lip@IR820 Gel effectively inhibited tumor cell migration, invasion, and angiogenesis. In vivo studies revealed that this liposome hydrogel prolonged local drug retention. When combined with near-infrared light irradiation, Bu&Ap-Lip@IR820 Gel significantly suppressed tumor recurrence while exhibiting favorable in vivo biocompatibility. Conclusion: This study developed a NIR-responsive composite liposome hydrogel integrating Bu multi-targeted antitumor properties, Ap anti-angiogenic effects, and IR820 photothermal therapeutic advantages. Through near-infrared responsiveness, it achieves localized precision drug release, effectively suppressing postoperative recurrence. This provides a novel and promising strategy for the clinical prevention and treatment of colon cancer recurrence.\u003Cbr>Keywords: temperature-sensitive hydrogel, multimodal therapy, recurrence of colon cancer, photothermal response, drug delivery |\n| --- |\n| Introduction\u003Cbr>Globally, colon cancer ranks third in incidence and second in mortality among malignant tumors.1 Laparoscopic surgery combined with adjuvant chemotherapy is currently the preferred clinical treatment for colon cancer.2 However, due to incomplete surgical resection and multidrug resistance (MDR) of tumor cells, about 33% of colon cancer patients will still have tumor recurrence after treatment, and the proportion of recurrence in the first three years after surgery is more than 80% .3,4 Although intraoperative intraperitoneal chemotherapy can effectively reduce the postoperative recurrence rate of colon cancer, the drug dose is not easy to control. Excessive local concentration and uneven distribution can easily cause nausea, vomiting, peritonitis, intestinal obstruction, and other adverse reactions, which seriously affect the quality |\n\n[https://doi.o","cbCaiuyWvjckbYnP","https://ap.wps.com/l/cbCaiuyWvjckbYnP","pdf",23583039,24,"English","# Background\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What is the main therapeutic goal of the injectable liposome hydrogel in this study?\",\"answer\":\"To inhibit postoperative recurrence of colon cancer by enabling localized, near-infrared-responsive drug release and photothermal therapy.\"},{\"question\":\"How were the thermosensitive liposomes and the composite hydrogel prepared?\",\"answer\":\"Thermosensitive liposomes co-loaded with bufalin and apatinib were prepared by the thin-film hydration method, then co-encapsulated with IR820 in an injectable PLGA-PEG-PLGA hydrogel to form a photothermally responsive composite.\"},{\"question\":\"What key effects were observed in vitro and in vivo?\",\"answer\":\"In vitro, the hydrogel inhibited tumor cell migration, invasion, and angiogenesis; in vivo, it prolonged local drug retention and, combined with near-infrared irradiation, significantly suppressed tumor recurrence while showing favorable biocompatibility.\"}]","An Injectable Photothermal Responsive Liposome Hydrogel Co-Loaded with Bufalin, Apatinib, and IR820 for Inhibiting Postoperative Recurrence of Colon Cancer | PDF",1790148970,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b0418186d17a643d2ae0bd6d149c60a6.webp",983,1272,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/18e82710aff8c288627d4f3f3765aec1.webp",982,1270,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a17c4c74b3fa0a342d9d0f693b79bcf2.webp",981,1269,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d68fce0057c4a365ffd15114e5ba57a.webp",980,1268]